Financing Biotech: Portfolio Theory and Netflix-Inspired Models
Bioverge
00:00
The Value of Death: Biotech Funding Challenges
This chapter discusses the concept of the 'value of death' in biotech and its relation to the financial perspective of translating science and moving therapies from discovery to proof of concept. It explores the application of portfolio theory and hedge fund strategies in managing portfolios of biomedical assets and attracting more capital for drug development.
Transcript
Play full episode
